Arbutus Biopharma (ABUS) Q3 2026 Earnings

30JulConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
-0.05
0.26
0.56
0.87

Details

Expected EPS
-0.02
Actual EPS
N/A
Surprise EPS
0.02
Surprise Percent
+100%

Description

Arbutus Biopharma (ABUS) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts